Detail akcie Alpha Teknova Rg online

Business Summary: Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary product categories, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. It supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Alpha Teknova Inc revenues increased 7% to $30.5M. Net loss decreased 41% to $12.5M. Revenues reflect Lab Essentials segment increase of 10% to $24.2M, Other segment increase of 19% to $1.4M, United States segment increase of 6% to $28.9M, International segment increase of 25% to $1.7M. Lower net loss reflects General and administrative - Balancing v decrease of 9% to $12.7M (expense).